Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment

Cancer is associated with single or multiple gene defects. Recently, much research has focused on incorporating genetic materials as one of the means to treat various types of carcinomas. RNA interference (RNAi) conveys an alternative genetic approach for cancer patients, especially when conventiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattab, Dima, Gazzali, Amirah Mohd, Bakhtiar, Athirah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309123/
https://www.ncbi.nlm.nih.gov/pubmed/34371702
http://dx.doi.org/10.3390/pharmaceutics13071009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309123/
https://www.ncbi.nlm.nih.gov/pubmed/34371702
http://dx.doi.org/10.3390/pharmaceutics13071009

Ejemplares similares